George Zavoico analyst

Currently out of the existing stock ratings of George Zavoico, 11 are a BUY (91.67%), 1 are a HOLD (8.33%).

George Zavoico

Work Performance Price Targets & Ratings Chart

Analyst George Zavoico, has had 75% of price targets met with an average potential upside of 136.28%, reached in 660 days on average. Previously, George Zavoico worked at B. RILEY.

George Zavoico has documented 26 price targets and ratings displayed on 7 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on PSTL, Postal Realty Trust at 13-Aug-2020.

Wall Street Analyst George Zavoico

Analyst best performing recommendations are on CBIO (CATALYST BIOSCIENCES).
The best stock recommendation documented was for CBIO (CATALYST BIOSCIENCES) on 12/8/2017. The price target of $1900 was fulfilled within 34 days with a profit of $527.75 (38.46%), with a performance score of 11.31.

Average potential price target upside

BLFS BioLife Solutions CBIO Catalyst Biosciences GERN Geron PSTL Postal Realty Trust VSTM Verastem ATNM Actinium Pharmaceuticals NVAX Novavax

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 19-Dec-2024

$30

3 months 11 days ago
(10-Aug-2026)

5/5 (100%)

$5.16 (20.77%)

277

Buy Since 04-Apr-2024

$31

$-7.61 (-19.71%)

$22

3 months 29 days ago
(23-Jul-2026)

2/2 (100%)

$0.23 (0.75%)

23

Buy Since 24-Feb-2020

$31

$-7.61 (-19.71%)

$33

3 months 30 days ago
(22-Jul-2026)

7/7 (100%)

$-0.15 (-0.48%)

243

Buy Since 18-Nov-2024

$32

$3.33 (11.61%)

$32

10 months 23 days ago
(29-Dec-2025)

1/7 (14.29%)

$6.88 (27.39%)

8

Buy Since 10-Nov-2020

$33

$33

1 years 1 months 18 days ago
(03-Oct-2025)

3/8 (37.5%)

$6.41 (24.11%)

69

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?